Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
32 studies found for:    Open Studies | "Carcinoma, Ductal, Breast"
Show Display Options
Rank Status Study
21 Recruiting Broccoli Sprout Extract in Treating Patients With Breast Cancer
Conditions: Ductal Breast Carcinoma;   Ductal Breast Carcinoma In Situ;   Estrogen Receptor Negative;   Estrogen Receptor Positive;   Invasive Breast Carcinoma;   Lobular Breast Carcinoma;   Postmenopausal;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Broccoli Sprout Extract;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Other: Placebo
22 Recruiting Pilot Study of Curcumin for Women With Obesity and High Risk for Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Gene Mutation;   BRCA2 Gene Mutation;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Dietary Supplement: curcumin;   Other: Biomarker analysis;   Other: Assessment of Dietary Intake;   Other: Daily Log
23 Recruiting Metformin Hydrochloride in Patients With Atypical Hyperplasia or In Situ Breast Cancer to Placebo in Decreasing Atypical Cells in Patients With Atypical Hyperplasia or in Situ Breast Cancer
Conditions: Atypical Ductal Breast Hyperplasia;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ
Interventions: Drug: metformin hydrochloride;   Other: placebo
24 Recruiting Caloric Restriction in Treating Patients With Stage 0-I Breast Cancer Undergoing Surgery and Radiation Therapy
Conditions: Ductal Breast Carcinoma in Situ;   Invasive Ductal Breast Carcinoma;   Invasive Lobular Breast Carcinoma;   Lobular Breast Carcinoma in Situ;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer
Interventions: Behavioral: Behavioral dietary intervention;   Procedure: Therapeutic conventional surgery;   Radiation: Radiation therapy;   Other: Counseling intervention;   Procedure: Quality-of-life assessment
25 Recruiting Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor Positive;   Invasive Breast Carcinoma;   Progesterone Receptor Positive;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer
Interventions: Radiation: Accelerated Partial Breast Irradiation;   Radiation: High-Dose Rate Brachytherapy;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
26 Recruiting Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Conditions: Ductal Breast Carcinoma In Situ;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Invasive Breast Carcinoma;   Multicentric Breast Carcinoma;   Multifocal Breast Carcinoma;   Synchronous Bilateral Breast Carcinoma
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Drug: Systemic Chemotherapy;   Drug: Tamoxifen Citrate
27 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors (NAVIGATE)
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
28 Recruiting Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Conditions: BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Ductal Breast Carcinoma In Situ;   Lobular Breast Carcinoma In Situ;   Stage 0 Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer
Interventions: Drug: Telapristone Acetate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
29 Recruiting Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer
Conditions: Ductal Breast Carcinoma in Situ;   Lobular Breast Carcinoma in Situ;   Male Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Dietary Supplement: omega-3 fatty acid;   Other: placebo;   Other: laboratory biomarker analysis
30 Recruiting Intraoperative Boost Radiotherapy With Electrons (IOERT) Followed By Hypofractionated Whole-Breast Irradiation (WBRT)
Condition: Invasive Lobular and Ductal Carcinoma
Interventions: Radiation: Hypofractionated Whole Breast Radiation Therapy;   Radiation: Intraoperative Electron Radiation Therapy
31 Recruiting Radiation Therapy in Treating Women With Early Stage Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: External beam boost;   Radiation: whole breast irradiation
32 Recruiting Breast Cancer Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
Conditions: Breast Cancer;   Precancerous Condition
Interventions: Other: medical chart review;   Other: questionnaire administration;   Other: study of socioeconomic and demographic variables;   Procedure: Excess human biological tissue;   Procedure: quality-of-life assessment

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page   
Study has passed its completion date and status has not been verified in more than two years.